The industrial scientific-supplies company agrees to acquire all shares outstanding for $24.00 each.
Danaher announced on Monday that it agreed to acquire biotech company Abcam in a deal valued at $5.7 billion.
It appeared that Abcam investors weren’t pleased with the premium. American depositary receipts of Abcam were dropping 3% in the premarket session. Shares of Danaher were flat in premarket trading Monday to $255.53.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Danaher to buy Abcam in deal valued at $5.7 billion By ReutersDanaher to buy Abcam in deal valued at $5.7 billion
Read more »
Danaher to acquire Abcam for $5.7 billion By Investing.comDanaher to acquire Abcam for $5.7 billion
Read more »
Abcam agrees to be acquired by Danaher in $5.7B dealAbcam Plc stock was up 0.4% in premarket trades Monday after it said it agreed to be acquired by Danaher Corp. for $24 a share in cash in a deal that values...
Read more »
BYD Electronic plans to buy Jabil manufacturing subsidiary for nearly $2.2 billionBYD Electronic is planning to buy a company that could own a manufacturing business in the Chinese cities of Chengdu and Wuxi for nearly $2.2 billion to...
Read more »
China Evergrande first-half net loss narrows to $4.5 blnProperty developer China Evergrande Group on Sunday reported a January-June net loss of 33 billion yuan ($4.53 billion) versus a 66.4 billion yuan loss in the same period a year ago.
Read more »
Maduro Tries to Buy a Spot at BRICS with Venezuelan OilNicolás Maduro offered Venezuela's vast oil reserves to the BRICS bloc, hoping to entice the China-led coalition to accept the rogue nation.
Read more »